Discovery of primary prostate cancer biomarkers using cross cancer learning

Prostate cancer (PCa), the second leading cause of cancer death in American men, is a relatively slow-growing malignancy with multiple early treatment options. Yet, a significant number of low-risk PCa patients are over-diagnosed and over-treated with significant and long-term quality of life effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Kaiyue, Arslanturk, Suzan, Craig, Douglas B., Heath, Elisabeth, Draghici, Sorin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128891/
https://www.ncbi.nlm.nih.gov/pubmed/34001952
http://dx.doi.org/10.1038/s41598-021-89789-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128891/
https://www.ncbi.nlm.nih.gov/pubmed/34001952
http://dx.doi.org/10.1038/s41598-021-89789-x

Ejemplares similares